3[3]Enver MK,Hoh I,Chinegwundoh FI.The management of aspirin in transurethral prostatectomy:Current practice in the UK[J].Ann R Coll Surg Engl,2006,88(3):280-283
4[4]Burger W,Chemnitius JM,Kneissl GD,et aL.Low-dose aspirin for secondary cardiovascular prevention-Cardiovascular risks after its perioperation withdrawal versus bleeding risks with its continu ation-review and meta-analysis[J].J Intern Med,2005,257(5):399-414
5[5]Ala-Opas MY,Gronlundss.Blood loss in long-term aspirin users undergoing transurethral prostatectomy[J].Scand J Urol Nephrol,1996,30(3):203-206
6[6]Cahill RA,McGreal GT,Crowe BH,et al.Duration of increased bleeding tendency after cessation of aspirin therapy[J].J Am Coll Surg,2005,20(4):564-73
7[7]Golino P,Ragni M,Cimmino G,et al.Role of tissue faetor pathway inhibitor in the regulation of tissue factor-dependent blood co agulation[J].Cardiovasc Drug Rev,2002,20(1):67-80
9Kadir Ceylan,Orhan Sünbül,Adem ?ahin,Mustafa Güne?. Ureteroscopic treatment of ureteral lithiasis with pneumatic lithotripsy: analysis of 287 procedures in a public hospital[J] 2005,Urological Research(6):422～425
